Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × alovudine × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms, Male 1 Anus Neoplasms 1

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 X-Rays 4 Phantoms, Imaging 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Carboplatin 3 Lapatinib 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 Biopsy 2 veliparib 1 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 palbociclib 1 olaparib 1 marizomib 1 larotrectinib 1 imetelstat 1 erdafitinib 1 dinutuximab 1 bempegaldesleukin 1 antineoplaston AS 2-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡